XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Treasury GENIUS Act Stablecoin Rules Back US Leadership
The US Treasury has stated that finalized rules under the GENIUS Act stablecoin framework are designed to support American leadership in digital finance, markin...
Lookonchain Says Pump.fun Deposited 129,798 SOL Worth $14.07M
On-chain analytics account Lookonchain reported that Pump. fun deposited 129,798 SOL, valued at approximately $14.
Irish Drug Dealer-Linked Wallet Moves 500 BTC to Coinbase
Blockchain intelligence firm Arkham reportedly flagged a wallet it links to an Irish drug dealer as the source of a 500 BTC transfer directed to Coinbase, accor...
Kazakhstan Restricts Access to Coinbase, HTX and Four Platforms
Kazakhstan has moved to restrict access to Coinbase, HTX, and four other cryptocurrency trading platforms, adding to a series of regulatory actions the country...
Report: Trump to Address Foreign Crypto Scams at White House Event
The framing around “foreign” crypto scams is significant. Cross-border fraud schemes, often operated from overseas jurisdictions, have become a documented focus...
CFTC: Cash Bitcoin Trades May Face Futures Rules
Under the Commodity Exchange Act, certain retail commodity transactions, including spot Bitcoin trades offered to consumers, can be treated as futures contracts...
